700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr. Heysell has field experience in HIV-drug-resistant TB-endemic areas, including rural South Africa (Tugela Ferry), where he lived during post-doctoral training at Yale in tropical infectious diseases. More recently, he has conducted field work in the Kilimanjaro region of Tanzania, where he has consulted at the national drug-resistant TB hospital, Kibong?oto, and has conducted research in partnership with investigators at the Kilimanjaro Clinical Research Institute. Dr. Heysell's research focuses on the understanding of anti-TB pharmacokinetics and the application of novel M. tuberculosis susceptibility testing, particularly in patients with multidrug-resistant TB, or with the co-morbid conditions of HIV or diabetes. He is currently funded by the NIH and non-governmental foundations for projects in Virginia, Tanzania, Bangladesh and Eastern Siberia.
Multidrug resistant tuberculosis (MDR-TB); pharmacokinetics; clinical application of diagnostics for TB; clinical trials to optimize TB treatment